Fate Therapeutics, Inc.FATENASDAQ

Revenue (LTM)

$7M

-51.2% YoY

Net Income (LTM)

$-136M

+26.8% YoY

Free Cash Flow

$-112M

Revenue CAGR (5Y)

-26.7%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	56	96↑72.4%	64↓34.0%	14↓78.5%	7↓51.2%
Gross Profit	50	83↑65.1%	-94↓213.5%	14↑114.6%	-6↓145.9%
Operating Income	-217	-308↓42.1%	-191↑38.2%	-210↓10.4%	-148↑29.8%
Net Income	-212	-282↓32.8%	-161↑42.9%	-186↓15.7%	-136↑26.8%
EBITDA	-211	-295↓39.5%	-172↑41.5%	-177↓2.5%	-127↑28.1%
EPS Diluted	-2.24	-2.91↓29.9%	-1.64↑43.6%	-1.64↓0.0%	-1.15↑29.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	134	61↓54.1%	42↓31.7%	36↓13.9%	47↑29.3%
Total Current Assets	633	502↓20.7%	332↓34.0%	292↓12.0%	209↓28.5%
Total Assets	921	706↓23.4%	506↓28.3%	441↓12.9%	319↓27.6%
Total Current Liabilities	81	114↑40.3%	39↓65.7%	39↓1.5%	36↓6.4%
Total Liabilities	243	222↓8.7%	138↓37.8%	122↓11.5%	112↓8.4%
Total Equity	679	484↓28.7%	368↓23.9%	319↓13.5%	207↓35.0%
Total Debt	115	109↓4.8%	104↓5.3%	85↓17.6%	78↓8.7%
Net Debt	-19	48↑355.8%	62↑28.5%	49↓20.2%	31↓36.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-163	-248↓52.4%	-132↑46.7%	-123↑7.1%	-106↑13.7%
Capital Expenditure	-51	-36↑29.9%	-6↑82.7%	-1↑88.1%	-6↓715.5%
Free Cash Flow	-214	-284↓32.9%	-138↑51.2%	-124↑10.7%	-112↑9.4%
Stock-Based Comp	54	79↑44.8%	43↓44.8%	41↓4.5%	25↓39.9%
Net Change in Cash	-34	-72↓114.0%	-19↑73.1%	-6↑70.1%	11↑281.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance